Training to improve attention control for treating alcohol use disorder
A Randomized Controlled Trial of Attentional Control Training for Treating Alcohol Use Disorder
This study is testing a new game-like training program to see if it can help people with alcohol use disorder focus less on alcohol and improve their recovery when combined with regular treatments.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 268 (estimated) |
| Ages | 18 Years to 75 Years |
| Sex | All |
| Sponsor | University of Southern Denmark Academic / other |
| Locations | 1 site (Valby, Capital Region of Denmark) |
| Trial ID | NCT05102942 on ClinicalTrials.gov |
What this trial studies
This study investigates the effectiveness of a gamified attentional control training program (AACTP) designed to retrain attentional biases toward alcohol cues in patients with alcohol use disorder (AUD). A total of 268 patients will be recruited from outpatient clinics in Denmark and randomly assigned to one of three treatment groups. The aim is to determine if adding AACTP to standard pharmacological and psychological treatments can enhance recovery outcomes for individuals with AUD.
Who should consider this trial
Good fit: Ideal candidates are Danish-speaking adults aged 18 to 65 who have completed detoxification and are currently undergoing primary treatment for alcohol use disorder.
Not a fit: Patients with severe psychiatric or neurological illnesses, color-blindness, or terminal physical conditions may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly reduce alcohol consumption and improve treatment outcomes for patients with alcohol use disorder.
How similar studies have performed: Previous studies have shown promise for attentional control training in community samples, but this approach is novel in clinical settings for alcohol use disorder.
Eligibility criteria
Show full inclusion / exclusion criteria
To be eligible to participate, patients must fulfill the following criteria. Inclusion criteria: They must (1) sign written informed consent, (2) be between 18 and 65 years old (because the intervention is web-based), (3) be fluent in Danish, (4) have completed detoxification (if deemed appropriate), (5) have been admitted to primary treatment within the past eight weeks. Exclusion criteria: Be color-blind, have a severe psychiatric or neurological illness (e.g., a psychotic disorder, intellectual disability, dementia) or terminal physical illness.
Where this trial is running
Valby, Capital Region of Denmark
- KABS City — Valby, Capital Region of Denmark, Denmark (Recruiting)
Study contacts
- Study coordinator: Angelina I Mellentin, Ph.D
- Email: amellentin@health.sdu.dk
- Phone: +4550517901
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.